Srishika Pharmaceutical Private Limited
About Srishika Pharmaceutical Private Limited
Data last updated:
Srishika Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2019PTC346450.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suprabha Rai and Ranvijay Kumar Rai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Amina 300 – D East Vinod Nagar, Delhi, India – 110091.
As per the financials filed for FY 2024, the company reported a revenue of ₹95,218, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹9,301 (net margin -9.8%) and EBITDA of -₹9,301 (EBITDA margin -9.8%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years.
Company details
Contact details
Srishika Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Amina 300 – D East Vinod Nagar, Delhi, India – 110091
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Srishika Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Srishika Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Srishika Pharmaceutical Private Limited, buy the company report.
Financials of Srishika Pharmaceutical Private Limited
FY 2025 filings availableSrishika Pharmaceutical Private Limited reported revenue of ₹95,218 (down 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over three years, including a 8% fall in the latest year. EBITDA fell 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9,301 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9,301 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.8% | ||||
| Net Profit Margin | -9.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Srishika Pharmaceutical Private Limited, buy the company report.
Board of directors of Srishika Pharmaceutical Private Limited
Srishika Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suprabha Rai | Director | 22 Feb 2019 | 7 Years 8 Months | Current |
| Ranvijay Kumar Rai | Director | 22 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Srishika Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mehul Organics Private Limited | ₹96,800 (FY 2025) | -96.0% | Ahmedabad, Gujarat, India | |||
| Goill Pharmaceuticals Private Limited | ₹96,698 (FY 2023) | Patna, Bihar, India | ||||
| Kroda International Ltd | ₹96,400 (FY 2025) | -45.0% | Kolkata, West Bengal, India | |||
| Ait Detergent Private Limited | ₹95,750 (FY 2022) | Deoria, Uttar Pradesh, India | ||||
| Onlynutra Products Private Limited | ₹95,581 (FY 2025) | -45.0% | Meerut, Uttar Pradesh, India | |||
| Srishika Pharmaceutical Private Limitedthis company | ₹95,218 (FY 2024) | -₹9,301 | -9.8% | -8.0% | Delhi, India | |
| Carole Drugs Private Limited | ₹95,214 (FY 2020) | -93.0% | Bangalore, Karnataka, India | |||
| No.1 Shreeshanti Agarbati (OPC) Private Limited | ₹94,900 (FY 2022) | Bhubaneswar, Odisha, India | ||||
| Benolance Enterprises Private Limited | ₹94,650 (FY 2024) | -97.0% | Nashik, Maharashtra, India | |||
| SK Hygiene Care Private Limited | ₹94,516 (FY 2021) | Mumbai, Maharashtra, India | ||||
| Dew-Tech Water Private Limited | ₹94,320 (FY 2024) | -4.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Srishika Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Srishika Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Srishika Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Srishika Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Srishika Pharmaceutical Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Ranvijay Kumar Rai was appointed as Director on 22 Feb 2019.
Frequently asked questions
Srishika Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 February 2019 (7+ years old) and is registered under CIN U74999DL2019PTC346450.
Srishika Pharmaceutical has 2 current directors:
- Suprabha Rai - Director
- Ranvijay Kumar Rai - Director
The latest financial statements of Srishika Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Srishika Pharmaceutical is U74999DL2019PTC346450. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Srishika Pharmaceutical was incorporated on 22 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Srishika Pharmaceutical by revenue are Mehul Organics Private Limited, Goill Pharmaceuticals Private Limited, Kroda International Ltd, Ait Detergent Private Limited, Onlynutra Products Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ranvijay Kumar Rai was appointed as Director on 22 Feb 2019. Suprabha Rai was appointed as Director on 22 Feb 2019.
The registered office of Srishika Pharmaceutical is at CO Amina 300 – D East Vinod Nagar, Delhi, India – 110091.
Srishika Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Srishika Pharmaceutical can be reached at its registered office: CO Amina 300 – D East Vinod Nagar, Delhi, India – 110091.
Srishika Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
